Recent News

• 03.04.2025 - Korro Bio at the TD Cowen 45th Annual Health Care Conference
• 03.04.2025 - Korro Bio at the TD Cowen 45th Annual Health Care Conference
• 02.26.2025 - Korro to Present at the TD Cowen 45th Annual Health Care Conference
• 02.26.2025 - Korro to Present at the TD Cowen 45th Annual Health Care Conference
• 01.13.2025 - Korro Bio at the J.P. Morgan 43rd Annual Healthcare Conference
• 01.13.2025 - Korro Bio at the J.P. Morgan 43rd Annual Healthcare Conference
• 01.13.2025 - Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update
• 01.13.2025 - Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update

Recent Filings

• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.11.2025 - 8-K Current report
• 02.11.2025 - 3 Initial statement of beneficial ownership of securities
• 02.05.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities